Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Finasteride's benefits outweigh its risks.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Severe hair loss may increase the risk of dying from COVID-19.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

CMV infection increases the risk of GvHD after bone marrow transplants.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Men and minority groups face higher risks and severe outcomes from SARS-CoV, MERS-CoV, and COVID-19.

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Doctors linked maternal drinking to infant mortality and national decline, leading to public awareness and changes in law.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.